Rural Libraries Promoting Walking and Walkability in Their Rural Communities

January 11, 2024 updated by: Oregon Health and Science University
The investigators will randomize 20 rural libraries to implement either a group-based walking (standard approach) or a group-based walking combined with a civic engagement program (combined approach). Each rural library will enroll between 15-20 participants. The investigators will compare the change in physical activity between participants in each group.

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Detailed Description

The goals of this study are:

  1. Increase the capacity of rural libraries to deliver evidence-based health promotion programs
  2. Compare the effects of a group-based walking program with a combined group-based plus civic engagement program on physical activity, cardiovascular fitness and collective efficacy among rural residents.
  3. Evaluate program implementation

Study Type

Interventional

Enrollment (Estimated)

331

Phase

  • Phase 2
  • Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Oregon
      • Portland, Oregon, United States, 97239
        • Oregon Health & Science University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Age 18 or older
  • Inactive (defined as engaging in physical activity <3 days per week)
  • Ability to walk for at least 20 minutes
  • Living within the rural community served by the local library
  • Ability to travel to the local library/location of walking group.

Exclusion criteria:

  • Participation/intention to participate in other lifestyle modification pro-gram(s)
  • Cognitive impairment
  • Inability to communicate due to severe uncorrected hearing loss or speech disorder or severe visual impairment (if precludes completion of assessments and/or intervention)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Walking only (Step It Up!)
A group-based, weekly walking program (Step It Up) where participants walk for up to 45 minutes.
Other: Walking only (Step It Up!)
Participants will meet weekly for 60 minutes and walk together as a group. Participants will progressively build up to walking for 45 minutes at a brisk pace. Walks will start with a check-in and end with stretching as a group.
Experimental: Combined (Step It Up! plus Change Club)
A group-based, weekly walking program (Step It Up) where participants walk for up to 45 minutes. Participants also spend 30 minutes each week in a civic engagement program (the Change Club) improving walkability in the community
Other: Walking only (Step It Up!)
Participants will meet weekly for 60 minutes and walk together as a group. Participants will progressively build up to walking for 45 minutes at a brisk pace. Walks will start with a check-in and end with stretching as a group.
Other: Combined (Step It Up! plus Civic Engagement)
Participants in the combined groups will meet weekly for 90 minutes with group members. They will participate in a group walk for 60 minutes followed by 30 minutes of civic engagement aimed at improving walkability in the community

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physical activity
Time Frame: Change from baseline physical activity at 6 months, 12 months, and 24 months.
Participants will be asked to wear an accelerometer for >10 hours/day for seven days at the wrist to measure physical activity. An accelerometer is a small device worn at the wrist that records acceleration, the change in velocity of a participant over time.
Change from baseline physical activity at 6 months, 12 months, and 24 months.
Cardio respiratory fitness
Time Frame: Change from baseline cardio respiratory fitness at 6 months, 12 months, and 24 months.
Participants will be asked to complete a six-minute walk test to measure cardiorespiratory fitness. The distance walked in 6 minutes will be recorded.
Change from baseline cardio respiratory fitness at 6 months, 12 months, and 24 months.
Collective Efficacy
Time Frame: Change from baseline collective efficacy at 6 months, 12 months, and 24 months
Participants will be asked to complete a survey regarding collective-efficacy, the Collective Efficacy Scale (Sampson and colleagues, 1997), which measures how well communities work together to make things happen.
Change from baseline collective efficacy at 6 months, 12 months, and 24 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Height
Time Frame: Baseline
Researchers will measure the height of participants in inches.
Baseline
Hip circumference
Time Frame: Change from baseline hip circumference at 6 months, 12 months, and 24 months.
Researchers will measure the hip circumference of participants in inches.
Change from baseline hip circumference at 6 months, 12 months, and 24 months.
Resting heart rate
Time Frame: Change from baseline resting heart rate at 6 months, 12 months, and 24 months.
Researchers will measure resting heart rate of participants by using heart rate monitor.
Change from baseline resting heart rate at 6 months, 12 months, and 24 months.
Weight
Time Frame: Change from baseline weight at 6 months, 12 months, and 24 months.
Researchers will measure the weight of participants in pounds.
Change from baseline weight at 6 months, 12 months, and 24 months.
Blood pressure
Time Frame: Change from baseline blood pressure at 6 months, 12 months, and 24 months.
Researchers will measure the both diastolic and systolic blood pressure of participants using a sphygmomanometer.
Change from baseline blood pressure at 6 months, 12 months, and 24 months.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Oregon Health and Science University

Collaborators

Texas A&M University
University of North Carolina, Greensboro

Investigators

  • Principal Investigator: Cynthia K Perry, PhD, Oregon Health & Science University School of Nursing

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 25, 2023

Primary Completion (Estimated)

September 30, 2025

Study Completion (Estimated)

December 31, 2025

Study Registration Dates

First Submitted

December 7, 2022

First Submitted That Met QC Criteria

December 28, 2022

First Posted (Actual)

January 10, 2023

Study Record Updates

Last Update Posted (Estimated)

January 15, 2024

Last Update Submitted That Met QC Criteria

January 11, 2024

Last Verified

December 1, 2023

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • STUDY00024665

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The proposed research will involve the collection of qualitative and quantitative data. The investigators will not share the qualitative data due to the potential to compromise participant identity and related ethical concerns. Quantitative data from the participants will include demographic, anthropometric, physiologic, and behavioral data. Identifiers will be removed from the final datasets prior to release for sharing. However, given the small populations of the targeted communities, data will only be made available through a data sharing agreement to prevent the possibility of identity disclosure. This agreement will ensure that the data are used for research purposes only, that it will be kept secure, and that it will be destroyed or returned following analysis completion.

IPD Sharing Time Frame

Data will become available once all manuscripts have been published.

IPD Sharing Access Criteria

Data will be made available through a data sharing agreement.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Physical Activity

Clinical Trials on Walking only (Step It Up!)

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Senegal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe